Dorsey Wright & Associates’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-367
Closed -$28K 294
2023
Q3
$28K Buy
+367
New +$28K 0.01% 185